| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |